Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Structural Integrity and Musculoskeletal

Modifiable Lifestyle Factors

Diet

Exercise and movement

Text Availability

Abstract

213

Full text

168

Free full text

Publication Types

Journal Article

214

Randomized Controlled Trial

116

Research Support, Non-U.S. Gov't

Clinical Trial

Comparative Study

Multicenter Study

Review

Systematic Review

Observational Study

Meta-Analysis

Controlled Clinical Trial

Research Support, N.I.H., Extramural

Research Support, U.S. Gov't, Non-P.H.S.

Case Reports

Letter

Retracted Publication

Clinical Trial, Phase III

Clinical Trial, Phase II

Comment

Network Meta-Analysis

Publication Year

From

Quick links

Individual year

2024

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Hydroxycholecalciferols""[mesh_terms]

217 Results

Searching titles within these results

D-hormone derivatives for the treatment of osteoporosis: from alfacalcidol to eldecalcitol.

Noboru Kubodera

Mini reviews in medicinal chemistry 2010;9(12):1416-22

Full Text

Abstract

Clinical effect of alfacalcidol in children with Henoch-Schönlein purpura: a prospective randomized controlled trial.

Ying Chen, Ming-Fang Shi, Qiang Fu

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2021;23(8):797-801

Free Full Text

Abstract

Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.

Hajime Orimo, Toshitaka Nakamura, Masao Fukunaga, Hiroaki Ohta, Takayuki Hosoi, Yukari Uemura, Tatsuhiko Kuroda, Nobuaki Miyakawa, Yasuo Ohashi, Masataka Shiraki

Current medical research and opinion 2011;27(6):1273-84

Full Text

Abstract

Dialysate calcium, alfacalcidol, and clinical outcomes: A post-hoc analysis of the J-DAVID trial.

Tomoaki Morioka, Masaaki Inaba, Masanori Emoto, Daijiro Kabata, Tetsuo Shoji, Shinya Nakatani, Katsuhito Mori, Ayumi Shintani, Kunitoshi Iseki

PloS one 2022;17(9):e0273195

Free Full Text

Abstract

VITAMIN D AND OPHTHALMOPATHIAS. A REVIEW.

P Hribová, Š Sotak

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 2022;78(4):153-156

Free Full Text

Abstract

A new look at the most successful prodrugs for active vitamin D (D hormone): alfacalcidol and doxercalciferol.

Noboru Kubodera

Molecules (Basel, Switzerland) 2010;14(10):3869-80

Free Full Text

Abstract

The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.

Rajiv Kumar, Ladan Zand

Endocrinology and metabolism clinics of North America 2018;46(4):983-1007

Free Full Text

Abstract

Effects of alfacalcidol on cardiovascular outcomes according to alkaline phosphatase levels in the J-DAVID trial.

Tatsufumi Oka, Yusuke Sakaguchi, Yoshitaka Isaka, Haruka Ishii, Daijiro Kabata, Ayumi Shintani, Shinya Nakatani, Tomoaki Morioka, Katsuhito Mori, Masaaki Inaba, Masanori Emoto, Tetsuo Shoji

Scientific reports 2022;12(1):15463

Free Full Text

Abstract

Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.

W J Gillespie, D A Henry, D L O'Connell, J Robertson

The Cochrane database of systematic reviews 2000

Full Text

Abstract

Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol.

Erich Schacht, Johann D Ringe

Rheumatology international 2004;24(4):189-97

Full Text

Abstract

Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial (JOINT) initiated by the Research Group of Adequate Treatment of Osteoporosis (A-TOP).

Masataka Shiraki, Tatsuhiko Kuroda, Nobuaki Miyakawa, Naohito Fujinawa, Kazumasa Tanzawa, Akiko Ishizuka, Shiro Tanaka, Yukari Tanaka, Takayuki Hosoi, Eiji Itoi, Shigeto Morimoto, Akira Itabashi, Toshitsugu Sugimoto, Toshihiko Yamashita, Itsuo Gorai, Satoshi Mori, Hideaki Kishimoto, Hideki Mizunuma, Naoto Endo, Yoshiki Nishizawa, Kunio Takaoka, Yasuo Ohashi, Hiroaki Ohta, Masao Fukunaga, Toshitaka Nakamura, Hajime Orimo

Journal of bone and mineral metabolism 2011;29(1):37-43

Full Text

Abstract

A prospective randomized study for the treatment of bone loss with vitamin d during kidney transplantation in children and adolescents.

Mohamed A Ghoneim, Moharam El-Sayed, Mohamed A Sobh, Amgad E El-Agroudy, Amr A El-Husseini

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;4(12):2052-7

Free Full Text

Abstract

Impact of bone mineral density in reducing fracture risk in patients receiving alendronate plus alfacalcidol therapy.

Hajime Orimo, Yukari Uemura, Eiji Itoi, Masataka Shiraki, Toshitaka Nakamura, Hiroaki Ohta, Masao Fukunaga

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2021;26(6):1085-1093

Full Text

Abstract

Clinical trials involving vitamin D analogs in prostate cancer.

Srinivasan Vijayakumar, Rajeshwari R Mehta, Philip S Boerner, S Packianathan, Rajendra G Mehta

Cancer journal (Sudbury, Mass.) 2006;11(5):362-73

Full Text

Abstract

The effect of vitamin D3 deficiency on the severity of depressive symptoms. Overview of current research.

Łukasz Święcicki, Bogdan Stefanowski, Anna Zofia Antosik-Wójcińska

Psychiatria polska 2017;51(3):437-454

Free Full Text

Abstract

Results: 1 – 15 / 217

Filters

Expert Opinion

Clinical Imbalances

Modifiable Lifestyle Factors

Text Availability

Publication Types

Publication Year

Results for ""Hydroxycholecalciferols""[mesh_terms]

D-hormone derivatives for the treatment of osteoporosis: from alfacalcidol to eldecalcitol.

Clinical effect of alfacalcidol in children with Henoch-Schönlein purpura: a prospective randomized controlled trial.

Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02.

Dialysate calcium, alfacalcidol, and clinical outcomes: A post-hoc analysis of the J-DAVID trial.

VITAMIN D AND OPHTHALMOPATHIAS. A REVIEW.

A new look at the most successful prodrugs for active vitamin D (D hormone): alfacalcidol and doxercalciferol.

The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.

Effects of alfacalcidol on cardiovascular outcomes according to alkaline phosphatase levels in the J-DAVID trial.

Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.

Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol.

Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial (JOINT) initiated by the Research Group of Adequate Treatment of Osteoporosis (A-TOP).

A prospective randomized study for the treatment of bone loss with vitamin d during kidney transplantation in children and adolescents.

Impact of bone mineral density in reducing fracture risk in patients receiving alendronate plus alfacalcidol therapy.

Clinical trials involving vitamin D analogs in prostate cancer.

The effect of vitamin D3 deficiency on the severity of depressive symptoms. Overview of current research.

Results for
""Hydroxycholecalciferols""[mesh_terms]